Skip to main content
. 2023 Jan 23;2023(1):CD008986. doi: 10.1002/14651858.CD008986.pub4

2.5. Analysis.

2.5

Comparison 2: Secondary outcomes ‐ Trials comparing medication reviews with standard care, Outcome 5: Hospital readmissions (due to drug‐related adverse events) ‐ 12 months